Clinical Trial Update: A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the efficacy and safety of rituximab in participants with systemic sclerosis (scleroderma) and related skin involvement ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Collagen Diseases
• Lung Fibrosis
• Scleroderma
• Skin Sclerosis
• Systemic Sclerosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Tokyo University | Conditions: Scleroderma, Systemic, Skin Sclerosis | Phase 2, Phase 3 | Status: COMPLETED